RUNX1::ETO translocations must precede CSF3R mutations to promote acute myeloid leukemia development

Affiliations

• ¹ Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
• ² Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA. [email protected].
• ³ Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. [email protected].
• ⁴ Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA. [email protected].
• ⁵ Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. [email protected].
• ⁶ Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, 97239, USA. [email protected].